MIXED DYSLIPIDEMIA
Clinical trials for MIXED DYSLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new MIXED DYSLIPIDEMIA trials appear
Sign up with your email to follow new studies for MIXED DYSLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot could help control high cholesterol and fats
Disease control OngoingThis study tests an experimental drug called BW-00112 in 145 adults with mixed dyslipidemia, a condition where blood fats like cholesterol and triglycerides are too high. Participants receive either the drug or a placebo as a shot under the skin, while continuing their usual stat…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE2 • Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 07:24 UTC
-
New cholesterol drug inclisiran tested in Real-World patients
Disease control OngoingThis study tracks 847 adults with high cholesterol or mixed dyslipidemia who are taking inclisiran along with other cholesterol medications. The goal is to see how much their LDL (bad) cholesterol drops after 10 months and how well they stick to the treatment. It is an observatio…
Matched conditions: MIXED DYSLIPIDEMIA
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
Does breakfast change how this drug works? new study investigates
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether taking the experimental drug AD-117 with or without food changes its safety or how much gets into the blood. About 60 healthy adults will each receive a single dose under both conditions. The goal is to gather information, not to treat any disease.
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE1 • Sponsor: Addpharma Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 07:48 UTC
-
Researchers track Real-World safety of new cholesterol combo
Knowledge-focused OngoingThis study is observing over 2,500 adults with high cholesterol or mixed dyslipidemia who are taking bempedoic acid (alone or with ezetimibe) as part of their normal care. The goal is to see how safe and effective the drug is in real-world settings, especially in Asian and Latin …
Matched conditions: MIXED DYSLIPIDEMIA
Sponsor: Daiichi Sankyo • Aim: Knowledge-focused
Last updated May 26, 2026 07:23 UTC
-
Real-World study tracks cholesterol Drug's performance in 5,000 patients
Knowledge-focused OngoingThis study observes 5,000 adults with high cholesterol who are taking bempedoic acid (alone or with ezetimibe) as part of their normal medical care. Researchers will track changes in cholesterol levels, heart events, side effects, and quality of life over one year. The goal is to…
Matched conditions: MIXED DYSLIPIDEMIA
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC